Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.
OBJECTIVE
The complexity of interactions between genes and the environment is a major challenge for type 1 diabetes studies. Nuclear chromatin is the interface between genetics and environment and the principal carrier of epigenetic information. Because histone tail modifications in chromatin are linked to gene transcription, we hypothesized that histone methylation patterns in cells from type 1 diabetic patients can provide novel epigenetic insights into type 1 diabetes and its complications.


METHODS
We used chromatin immunoprecipitation (ChIP) linked to microarray (ChIP-chip) approach to compare genome-wide histone H3 lysine 9 dimethylation (H3K9me2) patterns in blood lymphocytes and monocytes from type 1 diabetic patients versus healthy control subjects. Bioinformatics evaluation of methylated candidates was performed by Ingenuity Pathway Analysis (IPA) tools.


RESULTS
A subset of genes in the type 1 diabetic cohort showed significant increase in H3K9me2 in lymphocytes but not in monocytes. CLTA4, a type 1 diabetes susceptibility gene, was one of the candidates displaying increased promoter H3K9me2 in type 1 diabetes. IPA identified two high-scoring networks that encompassed genes showing altered H3K9me2. Many of them were associated with autoimmune and inflammation-related pathways, such as transforming growth factor-beta, nuclear factor-kappaB, p38 mitogen-activated protein kinase, toll-like receptor, and interleukin-6. IPA also revealed biological relationships between these networks and known type 1 diabetes candidate genes.


CONCLUSIONS
The concerted and synergistic alteration of histone methylation within the identified network in lymphocytes might have an effect on the etiology of type 1 diabetes and its complications. These studies provide evidence of a novel association between type 1 diabetes and altered histone methylation of key genes that are components of type 1 diabetes-related biological pathways and also a new understanding of the pathology of type 1 diabetes.
Miao
Feng
F
Department of Diabetes, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Smith
David D
DD
Zhang
Lingxiao
L
Min
Andrew
A
Feng
Wei
W
Natarajan
Rama
R
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002843:Chromatin / Q000235:genetics*; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics*; D004777:Environment; D044127:Epigenesis, Genetic / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006657:Histones / Q000235:genetics*; D006801:Humans; D050417:Insulin-Secreting Cells / Q000473:pathology; D008214:Lymphocytes / Q000378:metabolism*; D008239:Lysine / Q000031:analogs & derivatives* / Q000235:genetics; D008875:Middle Aged; D020411:Oligonucleotide Array Sequence Analysis; D016133:Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000276:immunology; D055815:Young Adult
D002843:Chromatin; D006657:Histones; C018926:epsilon N-dimethyllysine; D008239:Lysine
J Biol Chem. 2007 May 4;282(18):13854-63
17339327
Genes Dev. 2002 Jul 15;16(14):1779-91
12130538
Nat Genet. 2005 Apr;37(4):391-400
15765097
J Immunol. 2008 Feb 15;180(4):2264-9
18250434
Cell. 2007 Jul 13;130(1):25-35
17632054
Nature. 2005 Sep 15;437(7057):436-9
16079795
Mol Cell. 2007 Aug 17;27(4):622-35
17707233
Nat Rev Genet. 2007 Apr;8(4):253-62
17363974
JAMA. 2002 May 15;287(19):2563-9
12020338
Nature. 2000 Jan 6;403(6765):41-5
10638745
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
11309499
Genes Dev. 2004 Jun 1;18(11):1263-71
15175259
Cell. 2005 Jan 28;120(2):169-81
15680324
Science. 2001 Aug 10;293(5532):1074-80
11498575
Nature. 1980 Oct 9;287(5782):509-16
7422003
Cell. 2006 May 5;125(3):483-95
16603237
JAMA. 2003 Oct 22;290(16):2159-67
14570951
J Biol Chem. 2001 Jul 6;276(27):25309-17
11316813
Nature. 2001 Nov 15;414(6861):277-83
11713521
Diabet Med. 2007 Jun;24(6):582-6
17490424
Mol Cell. 2003 Dec;12(6):1591-8
14690610
Science. 2000 Dec 22;290(5500):2306-9
11125145
Mol Cell Biol. 2005 Jun;25(11):4650-61
15899867
Annu Rev Immunol. 2002;20:29-53
11861596
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9047-52
18579779
Trends Genet. 2003 Nov;19(11):629-39
14585615
Nat Genet. 2005 Oct;37(10):1090-7
16155569
Trends Genet. 2004 Aug;20(8):350-8
15262407
Nature. 1994 Sep 8;371(6493):130-6
8072542
Genome Biol. 2004;5(10):R80
15461798
Annu Rev Biochem. 2006;75:243-69
16756492
Nat Cell Biol. 2007 Mar;9(3):347-53
17277772
Biometrics. 2007 Sep;63(3):787-96
17825010
Nature. 2007 May 24;447(7143):433-40
17522677
J Immunol. 2008 Feb 1;180(3):1929-37
18209091
Nat Genet. 2007 Jul;39(7):857-64
17554260
Mol Cell Biol. 2006 Sep;26(18):6890-901
16943430
J Biol Chem. 2004 Apr 23;279(17):18091-7
14976218
Diabetes. 2003 May;52(5):1300-5
12716770
Nature. 2005 Jun 30;435(7046):1262-6
15988529
Mol Cell. 2003 Dec;12(6):1577-89
14690609